Posted On: 05/14/2014 8:50:41 PM
Post# of 63742
$PVCT at breakout. Pr. $2.85
called 9/19/13 $ 0.80
Provectus Biopharmaceuticals’ PV-10 Data Show Exceptional
Complete Response Rates in Refractory Melanoma Patients
2014-05-14 17:10 ET - News Release
recent trades
Stockwatch
Website
10-Q 5/8/14
O/S shares 173,125,972
% Buy Opinion (composite)
called 9/19/13 $ 0.80
Provectus Biopharmaceuticals’ PV-10 Data Show Exceptional
Complete Response Rates in Refractory Melanoma Patients
2014-05-14 17:10 ET - News Release
recent trades
Stockwatch
Website
10-Q 5/8/14
O/S shares 173,125,972
% Buy Opinion (composite)
(0)
(0)Scroll down for more posts â–Ľ
